These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9626379)

  • 21. Stability of spironolactone in an extemporaneously prepared suspension at two temperatures.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1993 Oct; 27(10):1198-9. PubMed ID: 8251687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of omeprazole in an extemporaneously prepared oral liquid.
    Quercia RA; Fan C; Liu X; Chow MS
    Am J Health Syst Pharm; 1997 Aug; 54(16):1833-6. PubMed ID: 9269520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of a new formulation of enalapril maleate tablet.
    Bibi R; Naqvi BS; Shoaib MH; Rahim N
    Pak J Pharm Sci; 2011 Apr; 24(2):211-5. PubMed ID: 21454172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design.
    Szabó ZI; Székely-Szentmiklósi B; Deák B; Székely-Szentmiklósi I; Kovács B; Zöldi K; Sipos E
    Acta Pharm; 2016 Jun; 66(2):191-206. PubMed ID: 27279063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS; Haribhakti RP; Parker GA
    Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposal of a new degradation mechanism of enalapril maleate and improvement of enalapril maleate stability in tablet formulation with different stabilizers.
    Chen J; Zhang LH; Xu RJ; Bu NJ; Zhang L
    Pharmazie; 2014 Apr; 69(4):277-80. PubMed ID: 24791591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of VIS spectrophotometric determination of enalapril maleate in substance, in tablets and estimation of ester group stability.
    Stanisz B
    Acta Pol Pharm; 1999; 56(6):431-4. PubMed ID: 10715888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of an extemporaneously compounded minoxidil oral suspension.
    Song Y; Chin ZW; Ellis D; Lwin EMP; Turner S; Williams D; Garg S
    Am J Health Syst Pharm; 2018 Mar; 75(5):309-315. PubMed ID: 29472513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of vancomycin in an extemporaneously compounded ophthalmic solution.
    Fuhrman LC; Stroman RT
    Am J Health Syst Pharm; 1998 Jul; 55(13):1386-8. PubMed ID: 9659967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1998 Sep; 55(17):1804-9. PubMed ID: 9775343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions.
    Polonini HC; Loures S; Lima LC; Ferreira AO; Brandão MA
    Int J Pharm Compd; 2016; 20(2):167-74. PubMed ID: 27323429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children.
    Nahata MC; Morosco RS; Brady MT
    Am J Health Syst Pharm; 2006 Feb; 63(3):254-7. PubMed ID: 16434784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of salt forms of enalapril.
    Kumar L; Amin A; Bansal AK
    Pharm Dev Technol; 2008; 13(5):345-57. PubMed ID: 18720234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100.
    Ramírez-Rigo MV; Olivera ME; Rubio M; Manzo RH
    Eur J Pharm Sci; 2014 May; 55():1-11. PubMed ID: 24456933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of levofloxacin in an extemporaneously compounded oral liquid.
    VandenBussche HL; Johnson CE; Fontana EM; Meram JM
    Am J Health Syst Pharm; 1999 Nov; 56(22):2316-8. PubMed ID: 10582824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of new potential ACE inhibitor in the aqueous solutions of different pH.
    Roskar R; Simoncic Z; Gartner A; Kmetec V
    J Pharm Biomed Anal; 2009 Feb; 49(2):295-303. PubMed ID: 19135817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of fluconazole in an extemporaneously prepared oral liquid.
    Yamreudeewong W; Lopez-Anaya A; Rappaport H
    Am J Hosp Pharm; 1993 Nov; 50(11):2366-7. PubMed ID: 8266965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.